News
Neutral
Nvidia, Eli Lilly to Invest Up to $1 Billion in AI Drug Development Lab

Nvidia and Eli Lilly are reported to be investing up to $1 billion (approximately 1.339 trillion won) into an AI-focused pharmaceutical research lab. Crypto Briefing highlighted that the collaboration could expand AI applications in life sciences and accelerate drug development.
Korean Source
This article is an English localization of a Korean-language crypto news report. Original headline: 엔비디아·일라이 릴리, AI 신약 연구소에 최대 10억달러 투입 보도